Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variant

被引:0
|
作者
Hoff, Fieke W. [1 ]
Griffen, Ti'ara L. [2 ]
Qiu, Yihua [3 ]
Kornblau, Steven M. [3 ]
机构
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[2] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA USA
[3] UT MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 448, Houston, TX 77030 USA
来源
EJHAEM | 2022年 / 3卷 / 04期
关键词
CLL; hairy cell leukaemia; leukemia; EXPRESSION; MUTATIONS;
D O I
10.1002/jha2.558
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classical hairy cell leukemia (HCL-c) and HCL variant (HCL-v) are recognized as separate entities with HCL-v having significantly shorter overall survival. Proteomic studies, shown to be prognostic in various forms of leukemia, have not been performed in HCL. We performed reverse phase protein array-based protein profiling with 384 antibodies in HCL-c (n = 12), HCL-v (n = 4), and normal B-cells (n = 5) samples. While HCL could be distinguished from normal based on unsupervised hierarchical clustering, overlap in protein expression patterns was seen between HCL-c and HCL-v, with similar to 10% of the proteins being differentially expressed, suggesting potential therapeutic targets.
引用
收藏
页码:1321 / 1325
页数:5
相关论文
共 50 条
  • [1] Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances
    Paillassa, Jerome
    Maitre, Elsa
    Troussard, Xavier
    CURRENT ONCOLOGY REPORTS, 2022, 24 (09) : 1133 - 1143
  • [2] Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances
    Jérôme Paillassa
    Elsa Maitre
    Xavier Troussard
    Current Oncology Reports, 2022, 24 : 1133 - 1143
  • [3] Breast Cancer Proteomic Profiling Using Reverse Phase Protein Array (RPPA)
    Negm, O. H.
    Alshareeda, A. T.
    Aleskandarany, M. A.
    Green, A. G.
    Ellis, I. O.
    Rakha, E. A.
    Tighe, P. J.
    JOURNAL OF PATHOLOGY, 2013, 231 : 13 - 13
  • [4] HAIRY-CELL LEUKEMIA (HCL) VARIANT - AN INTERMEDIATE DISEASE BETWEEN HCL AND B PROLYMPHOCYTIC LEUKEMIA
    CATOVSKY, D
    OBRIEN, M
    MELO, JV
    WARDLE, J
    BROZOVIC, M
    SEMINARS IN ONCOLOGY, 1984, 11 (04) : 362 - 369
  • [5] Comparison of IgH gene rearrangement configuration between hairy cell leukemia (HCL) and hairy cell leukemia variant (HCL-v).
    Gonzalez, D
    Morilla, R
    Morilla, A
    Else, M
    Osuji, N
    Catovsky, D
    Dearden, C
    Morgan, GJ
    Matutes, E
    BLOOD, 2005, 106 (11) : 330B - 330B
  • [6] Reverse Phase Protein Array (RPPA) Global Workshop
    Yamada, Tesshi
    REVERSE PHASE PROTEIN ARRAYS: FROM TECHNICAL AND ANALYTICAL FUNDAMENTALS TO APPLICATIONS, 2019, 1188 : V - V
  • [7] Reverse Phase Protein Array (RPPA) of High Risk ALL
    Seyfried, F.
    Accordi, B.
    Queudeville, M.
    Eckhoff, S. M.
    Milani, G.
    Galla, L.
    Giordan, M.
    Kraus, J.
    Basso, G.
    Kestler, H.
    te Kronnie, G.
    Debatin, K. M.
    Meyer, L. H.
    KLINISCHE PADIATRIE, 2012, 224 (03): : 218 - 218
  • [8] Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib
    Paillassa, Jerome
    Safa, Firas
    Troussard, Xavier
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [9] p53 allele deletion and trisomy 12 in hairy cell leukemia (HCL) and hairy cell leukemia variant (HCL-V). Clinicopathological correlations.
    Vallianatou, K
    Brito-Babapulle, V
    Matutes, E
    Atkinson, S
    Catovsky, D
    BLOOD, 1998, 92 (10) : 226A - 227A
  • [10] Reverse Phase Protein Lysate Array (RPPA) Identifies Differential Protein Expression in Uterine Carcinosarcoma
    Euscher, E. D.
    Wei, C.
    Russell, B. R.
    LABORATORY INVESTIGATION, 2011, 91 : 244A - 244A